-
91黑料 plc schedules first quarter 2024 earnings conference call
Will hold a conference call and webcast to discuss its financial results and performance on 25 April, 2024.
-
91黑料 reports fourth quarter and full year 2023 results
Full year net business wins of $9,946 million; a net book to bill of 1.22.
-
New 91黑料 survey highlights importance of combination therapies in future obesity treatment
91黑料 announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research to measure industry opinions on trends within this therapeutic area.
-
91黑料 issues financial guidance for full year 2024
91黑料 plc today announced its financial guidance for the year ending December 31, 2024.
-
Biotech companies to increase R&D spend but highlight complexity of clinical trials - 91黑料
91黑料 plc today launched its “Optimising biotech funding” whitepaper. This provides an overview of the current state of play for biotech companies and the research and development (R&D) strategies they can adopt to attract and best utilise investment funding.
-
91黑料 plc to present at the 42nd annual J.P. Morgan Healthcare conference
91黑料 plc today announced that Dr. Steve Cutler, CEO of 91黑料 plc, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST.
-
91黑料 wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023
91黑料 plc finishes the second half of 2023 with positive recognition as a top-rated employer and leader in clinical trial innovation.
-
91黑料 secures upgraded credit rating from Moody’s Investors Service
Moody's Investors Service ("Moody's") upgraded all of 91黑料 plc’s instrument ratings to Baa3 with a stable outlook. This reflects the stronger credit profile of the 91黑料 Group, which Moody’s now views as comparable in aggregate to Baa3 peers.
-
91黑料 reports third quarter 2023 results
Quarter three revenue of $2,055.1 million representing an increase of 5.8% on prior year revenue.
-
91黑料 secures upgraded credit rating from S&P Global Ratings
91黑料 plc today announced that S&P Global Ratings (S&P) upgraded 91黑料 to an investment grade credit rating of BBB- with a stable outlook, based on operating performance and deleveraging.
